Healing
Conditions
Keywords
Shave Biopsy management, Biopsy/adverse effects[Mesh], Biopsy/complications[Mesh])
Brief summary
Shave biopsies are often uncomfortable during the healing process. This is a preliminary study to determine if patients and clinicians prefer using PolyMem formulating dressings on shave biopsy sites compared to the current standard of practice, which is antibiotic ointment covered with a band-aid type dressing.
Detailed description
Only individuals who require 2 shave biopsies on the same treatment day will be entered in the study. Each participant serves as their own control.
Interventions
Shapes by PolyMem dressing on one site compared to antibiotic ointment covered with band-aid type dressing on second site
Shapes by PolyMem Silver dressing on one site compared to antibiotic ointment covered with band-aid type dressing on second site
Shapes by PolyMem dressing on one site. Shapes by PolyMem Silver dressing on other site.
Sponsors
Study design
Eligibility
Inclusion criteria
* Individuals that are going to have two shave biopsies performed on the same day will be evaluated for inclusion in the study.
Exclusion criteria
* Those that have used systemic corticosteroids in the last three months. * Those with any medical condition leading to immunosuppression * Those with a history of keloid formation * Those with documented compromised wound healing potential * History of psoriasis or eczema in the last 2 years * Those with an active infection * Those that use aspirin or non-steroidal anti-inflammatory drugs more than 3 times per week for pain (daily low dose aspirin use for cardiovascular health is not an
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preference by both clinician and consumer of dressing choice in managing shave biopsy sites. | At completion of protocol |
Secondary
| Measure | Time frame |
|---|---|
| Evaluations and comparisons by both treating physician and blinded physician of each site for differences in inflammation, signs of possible infection, reepithelialization and cosmetic appearance | At completion of protocol |
Countries
United States